-
1
-
-
13744256171
-
Efficacy and tolerability of ziprasidone versus risperidone in patients with acute exacerbation of schizophrenia or schizoaffective disorder: an 8-week, double-blind, multicenter trial
-
Addington D.R., Pantelis C., Dineen M., Benattia I., and Romano S.J. Efficacy and tolerability of ziprasidone versus risperidone in patients with acute exacerbation of schizophrenia or schizoaffective disorder: an 8-week, double-blind, multicenter trial. J Clin Psychiatry 65 (2004) 1624-1633
-
(2004)
J Clin Psychiatry
, vol.65
, pp. 1624-1633
-
-
Addington, D.R.1
Pantelis, C.2
Dineen, M.3
Benattia, I.4
Romano, S.J.5
-
2
-
-
0031680745
-
Visual cognitive dysfunction in depression: an event-related potential study
-
Bange F., and Bathien N. Visual cognitive dysfunction in depression: an event-related potential study. Electroencephalogr Clin Neurophysiol 108 (1998) 472-481
-
(1998)
Electroencephalogr Clin Neurophysiol
, vol.108
, pp. 472-481
-
-
Bange, F.1
Bathien, N.2
-
3
-
-
1942500219
-
Occupancy of agonist drugs at the 5-HT1A receptor
-
Bantick R.A., Rabiner E.A., Hirani E., de Vries M.H., Hume S.P., and Grasby P.M. Occupancy of agonist drugs at the 5-HT1A receptor. Neuropsychopharmacology 29 (2004) 847-859
-
(2004)
Neuropsychopharmacology
, vol.29
, pp. 847-859
-
-
Bantick, R.A.1
Rabiner, E.A.2
Hirani, E.3
de Vries, M.H.4
Hume, S.P.5
Grasby, P.M.6
-
4
-
-
33846581048
-
Effects of adjunctive antidepressant therapy with quetiapine on clinical outcome, quality of sleep and daytime motor activity in patients with treatment resistant depression
-
Baune B.T., Caliskan S., and Todder D. Effects of adjunctive antidepressant therapy with quetiapine on clinical outcome, quality of sleep and daytime motor activity in patients with treatment resistant depression. Hum Psychopharmacol 22 (2006) 1-9
-
(2006)
Hum Psychopharmacol
, vol.22
, pp. 1-9
-
-
Baune, B.T.1
Caliskan, S.2
Todder, D.3
-
5
-
-
0023098727
-
Changes in auditory P3 event-related potential in schizophrenia and depression
-
Blackwood D.H., Whalley L.J., Christie J.E., Blackburn I.M., St Clair D.M., and McInnes A. Changes in auditory P3 event-related potential in schizophrenia and depression. Br J Psychiatry 150 (1987) 154-160
-
(1987)
Br J Psychiatry
, vol.150
, pp. 154-160
-
-
Blackwood, D.H.1
Whalley, L.J.2
Christie, J.E.3
Blackburn, I.M.4
St Clair, D.M.5
McInnes, A.6
-
6
-
-
0025913261
-
Event-related potentials in depression: influence of task, stimulus hemifield and clinical features on P3 latency
-
Bruder G.E., Towey J.P., Stewart J.W., Friedman D., Tenke C., and Quitkin F.M. Event-related potentials in depression: influence of task, stimulus hemifield and clinical features on P3 latency. Biol Psychiatry 30 (1991) 233-246
-
(1991)
Biol Psychiatry
, vol.30
, pp. 233-246
-
-
Bruder, G.E.1
Towey, J.P.2
Stewart, J.W.3
Friedman, D.4
Tenke, C.5
Quitkin, F.M.6
-
7
-
-
15744400568
-
A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression
-
Calabrese J.R., Keck Jr. P.E., Macfadden W., Minkwitz M., Ketter T.A., Weisler R.H., et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry 162 (2005) 1351-1360
-
(2005)
Am J Psychiatry
, vol.162
, pp. 1351-1360
-
-
Calabrese, J.R.1
Keck Jr., P.E.2
Macfadden, W.3
Minkwitz, M.4
Ketter, T.A.5
Weisler, R.H.6
-
9
-
-
0035903767
-
The impact of transcranial magnetic stimulation on cognitive processing: an event-related potential study
-
Evers S., Böckermann I., and Nyhuis P.W. The impact of transcranial magnetic stimulation on cognitive processing: an event-related potential study. NeuroReport 12 (2001) 2915-2918
-
(2001)
NeuroReport
, vol.12
, pp. 2915-2918
-
-
Evers, S.1
Böckermann, I.2
Nyhuis, P.W.3
-
10
-
-
0015828197
-
Inter-and intra-rater reliability of the Brief Psychiatric Rating Scale
-
Flemenbaum A., and Zimmermann R.L. Inter-and intra-rater reliability of the Brief Psychiatric Rating Scale. Psychol Rep 32 (1973) 783-792
-
(1973)
Psychol Rep
, vol.32
, pp. 783-792
-
-
Flemenbaum, A.1
Zimmermann, R.L.2
-
11
-
-
0027335984
-
P300 amplitude in non-bipolar, melancholic depression
-
Gangadhar B.N., Ancy J., Janakiramaiah N., and Umapathy C. P300 amplitude in non-bipolar, melancholic depression. J Affect Disord 28 (1993) 57-60
-
(1993)
J Affect Disord
, vol.28
, pp. 57-60
-
-
Gangadhar, B.N.1
Ancy, J.2
Janakiramaiah, N.3
Umapathy, C.4
-
12
-
-
33344467623
-
Extrapyramidal side effects with atypical neuroleptics in bipolar disorder
-
Ghaemi S.N., Hsu D.J., Rosenquist K.J., Pardo T.B., and Goodwin F.K. Extrapyramidal side effects with atypical neuroleptics in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 30 (2006) 209-213
-
(2006)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.30
, pp. 209-213
-
-
Ghaemi, S.N.1
Hsu, D.J.2
Rosenquist, K.J.3
Pardo, T.B.4
Goodwin, F.K.5
-
13
-
-
0014186152
-
Development of a rating scale for primary depressive illness
-
Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6 (1967) 278-296
-
(1967)
Br J Soc Clin Psychol
, vol.6
, pp. 278-296
-
-
Hamilton, M.1
-
14
-
-
4644371360
-
The impact of the selective monoamine reuptake inhibitors reboxetine and citalopram on visually-evoked event-related potentials in depressed patients
-
Hetzel G., Moeller O., Erfurth A., Michael N., Rothermundt M., Arolt V., et al. The impact of the selective monoamine reuptake inhibitors reboxetine and citalopram on visually-evoked event-related potentials in depressed patients. Pharmacopsychiatry 37 (2004) 200-205
-
(2004)
Pharmacopsychiatry
, vol.37
, pp. 200-205
-
-
Hetzel, G.1
Moeller, O.2
Erfurth, A.3
Michael, N.4
Rothermundt, M.5
Arolt, V.6
-
15
-
-
15044346892
-
The astroglial protein S100B and visually evoked event-related potentials before and after antidepressant treatment
-
Hetzel G., Moeller O., Evers S., Erfurth A., Ponath G., Arolt V., et al. The astroglial protein S100B and visually evoked event-related potentials before and after antidepressant treatment. Psychopharmacology (Berl) 178 (2005) 161-166
-
(2005)
Psychopharmacology (Berl)
, vol.178
, pp. 161-166
-
-
Hetzel, G.1
Moeller, O.2
Evers, S.3
Erfurth, A.4
Ponath, G.5
Arolt, V.6
-
16
-
-
0032808996
-
A study of P300-event related evoked potential in the patients of major depression
-
Himani A., Tandon O.P., and Bhatia M.S. A study of P300-event related evoked potential in the patients of major depression. Indian J Physiol Pharmacol 43 (1999) 367-372
-
(1999)
Indian J Physiol Pharmacol
, vol.43
, pp. 367-372
-
-
Himani, A.1
Tandon, O.P.2
Bhatia, M.S.3
-
17
-
-
0037303744
-
P300 changes in major depressive disorders with and without psychotic features
-
Karaaslan F., Gonul A.S., Oguz A., Erdinc E., and Esel E. P300 changes in major depressive disorders with and without psychotic features. J Affect Disord 73 (2003) 283-287
-
(2003)
J Affect Disord
, vol.73
, pp. 283-287
-
-
Karaaslan, F.1
Gonul, A.S.2
Oguz, A.3
Erdinc, E.4
Esel, E.5
-
18
-
-
33646681652
-
A 24-week randomized study of olanzapine versus ziprasidone in the treatment of schizophrenia or schizoaffective disorder in patients with prominent depressive symptoms
-
Kinon B.J., Lipkovich I., Edwards S.B., Adams D.H., Ascher-Svanum H., and Siris S.G. A 24-week randomized study of olanzapine versus ziprasidone in the treatment of schizophrenia or schizoaffective disorder in patients with prominent depressive symptoms. J Clin Psychopharmacol 26 (2006) 157-162
-
(2006)
J Clin Psychopharmacol
, vol.26
, pp. 157-162
-
-
Kinon, B.J.1
Lipkovich, I.2
Edwards, S.B.3
Adams, D.H.4
Ascher-Svanum, H.5
Siris, S.G.6
-
19
-
-
33845613504
-
Quetiapine in combination with citalopram in patients with unipolar psychotic depression
-
Konstantinidis A., Hrubos W., Nirnberger G., Windhager E., Lehofer M., Aschauer H., et al. Quetiapine in combination with citalopram in patients with unipolar psychotic depression. Prog Neuropsychopharmacol Biol Psychiatry 31 (2007) 242-247
-
(2007)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.31
, pp. 242-247
-
-
Konstantinidis, A.1
Hrubos, W.2
Nirnberger, G.3
Windhager, E.4
Lehofer, M.5
Aschauer, H.6
-
20
-
-
0028934165
-
Assessment of extrapyramidal symptoms during acute neuroleptic treatment
-
Mazure C.M., Cellar J.S., Browers Jr. M.D., Nelson J.C., Takeshita J., and Zigun B. Assessment of extrapyramidal symptoms during acute neuroleptic treatment. J Clin Psychiatry 56 (1995) 94-100
-
(1995)
J Clin Psychiatry
, vol.56
, pp. 94-100
-
-
Mazure, C.M.1
Cellar, J.S.2
Browers Jr., M.D.3
Nelson, J.C.4
Takeshita, J.5
Zigun, B.6
-
21
-
-
0018425438
-
A new depression scale designed to be sensitive to change
-
Montgomery S.A., and Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 134 (1979) 382-389
-
(1979)
Br J Psychiatry
, vol.134
, pp. 382-389
-
-
Montgomery, S.A.1
Asberg, M.2
-
22
-
-
1842855918
-
Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder
-
Papakostas G.I., Petersen T.J., Nierenberg A.A., Murakami J.L., Alpert J.E., Rosenbaum J.F., et al. Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder. J Clin Psychiatry 65 (2004) 217-221
-
(2004)
J Clin Psychiatry
, vol.65
, pp. 217-221
-
-
Papakostas, G.I.1
Petersen, T.J.2
Nierenberg, A.A.3
Murakami, J.L.4
Alpert, J.E.5
Rosenbaum, J.F.6
-
23
-
-
0030603836
-
Rapid rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression
-
Pascual-Leone A., Rubio B., Pallardo F., and Catala M.D. Rapid rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression. Lancet 348 (1996) 233-237
-
(1996)
Lancet
, vol.348
, pp. 233-237
-
-
Pascual-Leone, A.1
Rubio, B.2
Pallardo, F.3
Catala, M.D.4
-
25
-
-
4744338410
-
Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder
-
Simpson G.M., Glick I.D., Weiden P.J., Romano S.J., and Siu C.O. Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder. Am J Psychiatry 161 (2004) 1837-1847
-
(2004)
Am J Psychiatry
, vol.161
, pp. 1837-1847
-
-
Simpson, G.M.1
Glick, I.D.2
Weiden, P.J.3
Romano, S.J.4
Siu, C.O.5
-
26
-
-
33751116553
-
Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study)
-
Thase M.E., Macfadden W., Weisler R.H., Chang W., Paulsson B., Khan A., et al. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study). J Clin Psychopharmacol 26 (2006) 600-609
-
(2006)
J Clin Psychopharmacol
, vol.26
, pp. 600-609
-
-
Thase, M.E.1
Macfadden, W.2
Weisler, R.H.3
Chang, W.4
Paulsson, B.5
Khan, A.6
-
27
-
-
33751103685
-
Locomotor activity and quality of sleep in Quetiapine treated patients with depression
-
Todder D., Caliskan S., and Baune B.T. Locomotor activity and quality of sleep in Quetiapine treated patients with depression. J Clin Psychopharmacol 26 (2006) 638-642
-
(2006)
J Clin Psychopharmacol
, vol.26
, pp. 638-642
-
-
Todder, D.1
Caliskan, S.2
Baune, B.T.3
-
28
-
-
0031782492
-
Auditory event related potentials in major depression: prolonged P300 latency and increased P200 amplitude
-
Vandoolaeghe E., van Hunsel F., Nuyten D., and Maes M. Auditory event related potentials in major depression: prolonged P300 latency and increased P200 amplitude. J Affect Disord 48 (1998) 105-113
-
(1998)
J Affect Disord
, vol.48
, pp. 105-113
-
-
Vandoolaeghe, E.1
van Hunsel, F.2
Nuyten, D.3
Maes, M.4
-
29
-
-
0017306128
-
-
World Medical Association: Declaration of Helsinki (1976). Recommendations guiding medical doctors in biomedical research involving human subjects. Med J Aust; 1: 206-7
-
-
-
-
30
-
-
0003031424
-
Changes in auditory P300 in patients with major depression and silent cerebral infarction
-
Yanai I., Fujikawa T., Osada M., Yamawaki S., and Touhouda Y. Changes in auditory P300 in patients with major depression and silent cerebral infarction. J Affect Disord 46 (1997) 263-271
-
(1997)
J Affect Disord
, vol.46
, pp. 263-271
-
-
Yanai, I.1
Fujikawa, T.2
Osada, M.3
Yamawaki, S.4
Touhouda, Y.5
|